A little more than a year has passed since Alligator Bioscience and Scandion Oncology announced the start of a joint project exploring the anti-tumour effect in chemotherapy-resistant tumours using mitazalimab and SCO-101 together with chemotherapy Folfirinox. The companies have now achieved a positive outcome of their preclinical study and concluded their collaboration.

Read the article about Alligator Bioscience at biostock.se:

https://www.biostock.se/en/2021/09/positive-outcome-for-alligator-biosciences-joint-study-with-scandion-oncology/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

https://news.cision.com/alligator-bioscience/r/biostock--positive-outcome-for-alligator-bioscience-s-joint-study-with-scandion-oncology,c3412983

(c) 2021 Cision. All rights reserved., source Press Releases - English